Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × ispinesib × Clear all

NCT00095992 2023-08-04

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms